J Korean Fract Soc.  2010 Oct;23(4):404-411. 10.12671/jkfs.2010.23.4.404.

VTE Prophylaxis in the Polytrauma Patient

• Lim SJ

• KMID: 1461500
• DOI: http://doi.org/10.12671/jkfs.2010.23.4.404

Abstract

No abstract available.

MeSH Terms

Humans

Figure

• 

  Fig. 1 (A) A 72-year-old female patient was referred to our hospital with left femoral neck fracture. She did not receive any thromboprophylaxis for 7 days following hip fracture. (B) On the next day, she underwent a bipolar hemiarthroplasty of the left hip with a modular cementless stem. At 6 hours after the operation, she suddenly complained of dyspnea and chest pain. (C) Enhanced computed tomography revealed filling defects (arrows) in the right and left pulmonary arteries. She was diagnosed with an acute pulmonary thromboembolism, and immediately underwent an open pulmonary thromboembolectomy. (D) Thromboembolic material removed from the right and left pulmonary arteries during pulmonary endarterectomy. Her postoperative course was uneventful, and she was able to ambulate with a walker on postoperative day 7.

Reference

1. American Academy of Orthopedic Surgeons Board of Directors. American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. 2007. 05. Available at: www.aaos.org/research/guidelines/PE_guideline.pdf.

2. Blann AD, Lip GY. Venous thromboembolism. BMJ. 2006. 332:215–219.

3. Callaghan JJ, Dorr LD, Engh GA, et al. American Colleg of Chest Physicians. Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians--are they appropriate for orthopaedic surgery? J Arthroplasty. 2005. 20:273–274.

4. Cardiovascular Disease Educational and Research Trust. Cyprus Cardiovascular Disease Educational and Research Trust. European Venous Forum. International Surgical Thrombosis Forum. International Union of Angiology. Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006. 25:101–161.

5. Chinese Orthopedic Association. Chinese Guideline for Venous Thromboembolism Prevention after Major Orthopedic Surgery. Chin J Orthop. 2009. 29:602–604.

6. Editorial Committee on Japanese Guideline for Prevention of Venous Thromboembolism. Japanese Guideline for Prevention of Venous Thromboembolism. 2004. Tokyo: Medical Front International Limited.

7. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American association of orthopedic surgeons and American college of chest physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009. 135:513–520.

8. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008. 133:6 suppl. 381S–453S.

9. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. Chest. 2004. 126:3 Suppl. 338S–400S.

10. House of Commons Health Committee. The prevention of venous thromboembolism in hospitalised patients. 2005. London: The Stationery Office Limited.

11. Kim YH, Oh SH, Kim JS. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br. 85:661–665.

12. Kobayashi T, Nakamura M, Sakuma M, et al. Incidence of pulmonary thromboembolism (PTE) and new guidelines for PTE prophylaxis in Japan. Clin Hemorheol Microcirc. 2006. 35:257–259.

13. Ko PS, Chan WF, Siu TH, Khoo J, Wu WC, Lam JJ. Deep venous thrombosis after total hip or knee arthroplasty in a "low-risk" Chinese population. J Arthroplasty. 2003. 18:174–179.

14. Korean Society on Thrombosis and Hemostasis. Japanese Guideline for Prevention of Venous Thromboembolism (Korean translation). Korean J Hematol. 2009. 16:1 Suppl. 75S–84S.

15. Leizorovicz A, Turpie AG, Cohen AT, et al. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost. 2005. 3:28–34.

16. National Institute for Health and Clinical Excellence. CG92 Venous thromboembolism-reducing the risk: NICE guideline. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. 2010. 01. Available at: www.nice.org.uk/nicemedia/pdf/CG92NICEGuidance.pdf.

17. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007. 22:6 Suppl 2. 24–28.

18. Piovella F, Wang CJ, Lu H, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005. 3:2664–2670.

19. Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997. 82:423–428.

20. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995. 108:978–981.

21. Sudo A, Sano T, Horikawa K, Yamakawa T, Shi D, Uchida A. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study. J Orthop Surg (Hong Kong). 2003. 11:174–177.

22. Yoo MC, Cho YJ, Ghanem E, Ramteke A, Kim KI. Deep vein thrombosis after total hip arthroplasty in Korean patients and D-dimer as a screening tool. Arch Orthop Trauma Surg. 2009. 129:887–894.